occurs in has participant quality has disease treated with drug ATORVASTATIN ROPINIROLE CYTARABINE MITOXANTRONE HYDROCHLORIDE TOLCAPONE RITUXIMAB TRASTUZUMAB DAPTOMYCIN TINIDAZOLE CERTOLIZUMAB PEGOL CABAZITAXEL secondary progressive multiple sclerosis prostate cancer Wegener's granulomatosis lymphocytic choriomeningitis Parkinson's disease breast cancer bacterial vaginosis cerebrovascular disease rheumatoid arthritis Crohn's disease Ritter's disease Elderly Adult urinary tract infection AE 10046571 CTCAE: E11614 NCIt: C50791 a urinary system AE that has an outcome of urnary tract infection AE SIDER: C0042029 HPO: HP_0000094 YH urinary system AE AE severity G2 AE severity G3 AE severity G4 AE severity G5